Form 10-Q, quarterly report
Maze Therapeutics, Inc., 10-Q filed 2026-08-11
Published 11 Aug 2026 · retrieved 12 Aug 2026, 02:30 EDT · version 1Official source
The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.
Filing record
¶1
10-Q filed with the Securities and Exchange Commission by Maze Therapeutics, Inc. (CIK 0001842295) on 2026-08-11.
¶2
Accession number 0001193125-26-344903. EDGAR reports the filing package as 10 MB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1842295/000119312526344903/0001193125-26-344903-index.htm.